<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_DTU-Denmark_Description skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:DTU-Denmark/Description</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><P><TITLE>New HTML template for the wiki</TITLE></P><DIV id="headerWrapper"><DIV id="Topnav" class="container"><DIV id="logo"><BUTTON id="hamburger" class="mobile-menue">☰</BUTTON><BUTTON id="arrow" class="mobile-menue">⇦</BUTTON><BUTTON id="a-down" class="mobile-menue mobile-scrole">Jump to</BUTTON></DIV><DIV id="navigation"><UL id="nav-items"><LI><A href="https://2016.igem.org/Team:DTU-Denmark/project" class="project nav-item" id="project">Project</A></LI><LI><A href="https://2016.igem.org/Team:DTU-Denmark/wetlab" class="wetlab nav-item" id="wetlab">Wetlab</A></LI><LI><A href="https://2016.igem.org/Team:DTU-Denmark/compute" class="compute nav-item" id="compute">Compute</A></LI><LI><A href="https://2016.igem.org/Team:DTU-Denmark/team" class="team nav-item" id="team">Team</A></LI><LI><A href="https://2016.igem.org/Team:DTU-Denmark/outreach" class="outreach nav-item" id="outreach">Outreach</A></LI></UL></DIV></DIV><DIV id="sub-navigation-wrapper"><DIV id="sub-navigation" class="container"><UL id="project-sub"><LI><A href="https://2016.igem.org/Team:DTU-Denmark/description" class="sub-nav-item">Description</A></LI><LI><A href="https://2016.igem.org/Team:DTU-Denmark/Proof" class="sub-nav-item">Proof of Concept</A></LI><LI><A href="https://2016.igem.org/Team:DTU-Denmark/achievements" class="sub-nav-item">Achievements</A></LI><LI><A href="https://2016.igem.org/Team:DTU-Denmark/Notebook" class="sub-nav-item">Notebook</A></LI><LI><A href="https://2016.igem.org/Team:DTU-Denmark/Safety" class="sub-nav-item">Safety</A></LI><LI><A href="https://2016.igem.org/Team:DTU-Denmark/Description" class="sub-nav-item">Parts</A></LI></UL><UL id="wetlab-sub"><LI><A href="https://2016.igem.org/Team:DTU-Denmark/substrate" class="sub-nav-item">Substrate</A></LI><LI><A href="https://2016.igem.org/Team:DTU-Denmark/products" class="sub-nav-item">Products</A></LI><LI><A href="https://2016.igem.org/Team:DTU-Denmark/molecular_toolbox" class="sub-nav-item">Molecular Toolbox</A></LI><LI><A href="https://2016.igem.org/Team:DTU-Denmark/molecular_interlab" class="sub-nav-item">Interlab</A></LI></UL><UL id="compute-sub"><LI><A href="https://2016.igem.org/Team:DTU-Denmark/Software" class="sub-nav-item">Codon Optimization</A></LI><LI><A href="https://2016.igem.org/Team:DTU-Denmark/Hardware" class="sub-nav-item">Microfermenter</A></LI><LI><A href="https://2016.igem.org/Team:DTU-Denmark/Model" class="sub-nav-item">Modeling</A></LI></UL><UL id="team-sub"><LI><A href="https://2016.igem.org/Team:DTU-Denmark/team_members" class="sub-nav-item">Team Members</A></LI><LI><A href="https://2016.igem.org/Team:DTU-Denmark/team_building" class="sub-nav-item">Team Building</A></LI><LI><A href="https://2016.igem.org/Team:DTU-Denmark/Attributions" class="sub-nav-item">Attributions</A></LI></UL><UL id="outreach-sub"><LI><A href="https://2016.igem.org/Team:DTU-Denmark/Collaborations" class="sub-nav-item">Collaborations</A></LI><LI><A href="https://2016.igem.org/Team:DTU-Denmark/HP/Silver" class="sub-nav-item">Practices</A></LI><LI><A href="https://2016.igem.org/Team:DTU-Denmark/HP/Gold" class="sub-nav-item">Integrated Practices</A></LI><LI><A href="https://2016.igem.org/Team:DTU-Denmark/Engagement" class="sub-nav-item">Biosensor</A></LI></UL></DIV></DIV></DIV><P><TITLE>Bootstrap Example</TITLE></P><DIV class="MYbody"><DIV class="masthead"><DIV class="container-fluid"><DIV class="row"><DIV class="col-md-12 thumbnail" style="background-image:url(https://static.igem.org/mediawiki/2016/5/56/T--DTU-Denmark--project-header.jpg)"><DIV class="caption"><DIV class="col-md-5 col-sm-5 col-xs-12 title"><H1>Parts<P class="lead">We have constructed four new basic parts, 4 composite parts, a plasmid backbone and improved two parts made by a previous team. The parts are all a part of our molecular toolbox for protein expression in <I>Yarrowia lipolytica</I>. </P></H1></DIV><DIV class="col-md-5 col-sm-5 hidden-xs intro"><BLOCKQUOTE class="blockquote-reverse"><P>&quot;A great building will never stand if you neglect the small bricks&quot;</P><SMALL>Ifeanyi Enoch Onuoha</SMALL></BLOCKQUOTE></DIV></DIV></DIV></DIV></DIV></DIV><DIV class="container"><DIV class="row"><DIV class="col-md-9 col-sm-10 colLeft"><DIV><H2 class="h2">Parts list</H2><BLOCKQUOTE class="visible-xs"><P>&quot;A great building will never stand if you neglect the small bricks&quot;</P><SMALL>Ifeanyi Enoch Onuoha</SMALL></BLOCKQUOTE><DIV class="grid-row"><DIV class="col-md-3 col-sm-3 col-xs-12"><A href="http://parts.igem.org/Part:BBa_K2117000">BBa_K2117000</A></DIV><DIV class="col-md-9 col-sm-9 col-xs-12"><P>Constitutive TEF1 promoter</P></DIV></DIV><DIV class="grid-row"><DIV class="col-md-3 col-sm-3 col-xs-12"><A href="http://parts.igem.org/Part:BBa_K2117001">BBa_K2117001</A></DIV><DIV class="col-md-9 col-sm-9 col-xs-12"><P>hrGFP codon-optimized for <I>Yarrowia lipolytica</I></P></DIV></DIV><DIV class="grid-row"><DIV class="col-md-3 col-sm-3 col-xs-12"><A href="http://parts.igem.org/Part:BBa_K2117002">BBa_K2117002</A></DIV><DIV class="col-md-9 col-sm-9 col-xs-12"><P>Composite part consisting of the TEF1 promoter and the human proinsulin gene codon-optimized for <I>Y. lipolytica</I></P></DIV></DIV><DIV class="grid-row"><DIV class="col-md-3 col-sm-3 col-xs-12"><A href="http://parts.igem.org/Part:BBa_K2117003">BBa_K2117003</A></DIV><DIV class="col-md-9 col-sm-9 col-xs-12"><P>Human proinsulin codon-optimized for <I>Y. lipolytica</I></P></DIV></DIV><DIV class="grid-row"><DIV class="col-md-3 col-sm-3 col-xs-12"><A href="http://parts.igem.org/Part:BBa_K2117004">BBa_K2117004</A></DIV><DIV class="col-md-9 col-sm-9 col-xs-12"><P>SCR1'-tRNA promoter expressing sgRNA</P></DIV></DIV><DIV class="grid-row"><DIV class="col-md-3 col-sm-3 col-xs-12"><A href="http://parts.igem.org/Part:BBa_K2117005">BBa_K2117005</A></DIV><DIV class="col-md-9 col-sm-9 col-xs-12"><P>hrGFP expressed by the constitutive TEF1 promoter</P></DIV></DIV><DIV class="grid-row"><DIV class="col-md-3 col-sm-3 col-xs-12"><A href="http://parts.igem.org/Part:BBa_K2117009">BBa_K2117009</A></DIV><DIV class="col-md-9 col-sm-9 col-xs-12"><P>Semi-synthetic shuttle vector pSB1A8YL</P></DIV></DIV><DIV class="grid-row"><DIV class="col-md-3 col-sm-3 col-xs-12"><A href="http://parts.igem.org/Part:BBa_K2117010">BBa_K2117010</A></DIV><DIV class="col-md-9 col-sm-9 col-xs-12"><P>Composite part of TEF1 and enhanced YFP </P></DIV></DIV><DIV class="grid-row"><DIV class="col-md-3 col-sm-3 col-xs-12"><A href="http://parts.igem.org/Part:BBa_K2117011">BBa_K2117011</A></DIV><DIV class="col-md-9 col-sm-9 col-xs-12"><P>Composite part of TEF1 and enhanced CFP</P></DIV></DIV><DIV class="grid-row"><DIV class="col-md-3 col-sm-3 col-xs-12"><A href="http://parts.igem.org/Part:BBa_K2117012">BBa_K2117012</A></DIV><DIV class="col-md-9 col-sm-9 col-xs-12"><P>Improved <A href="http://parts.igem.org/Part:BBa_K530001">BBa_K530001</A> (<EM>crtE</EM>)</P></DIV></DIV><DIV class="grid-row"><DIV class="col-md-3 col-sm-3 col-xs-12"><A href="http://parts.igem.org/Part:BBa_K2117013">BBa_K2117013</A></DIV><DIV class="col-md-9 col-sm-9 col-xs-12"><P>Improved <A href="http://parts.igem.org/Part:BBa_K530002">BBa_K530002</A>  (<EM>crtI</EM>)</P></DIV></DIV></DIV><DIV><H2 class="h2">Improvement and Characterization of Two Existing Parts</H2><P>
            In our laboratory work, we wanted to work with the two BioBricks; <A href="http://parts.igem.org/Part:BBa_K530001">BBa_K530001</A> (<EM>crtE</EM> gene) and <A href="http://parts.igem.org/Part:BBa_K530002">BBa_K530002</A> (<EM>crtI</EM> gene) created by the John Hopkins iGEM team 2011. The genes encode the two enzymes Geranylgeranyl Diphosphate Synthase and Phytoene Desaturase, respectively,  both from the wildtype strain of <I>xanthophyllomyces dendrorhous</I> used in the biosynthesis of beta-Carotene.
            </P><P>
            When looking into the specifications of these BioBricks, we realized that both genes contained illegal restriction sites. 
            </P><P><A href="http://parts.igem.org/Part:BBa_K530001">BBa_K530001</A> contained an AgeI restriction site making the part incompatible with the RFC25 Freiburg Standard. The RFC25 standard allows for in-frame assembly of protein domains.
            <A href="http://parts.igem.org/Part:BBa_K530002">BBa_K530002</A> contained the illegal restriction site BglII making the part incompatible with the RFC21 Berkely Standard, which enables in-frame assembly of proteins. 
            </P><P>
            We wanted to overcome these obstacle by removing the illegal restriction sites from the above described Biobricks. 
            </P><H3 class="h3">How did we do it?</H3><P>
            The illegal restriction sites were removed using site directed mutagenesis with primers containing nucleotide substitutions in the two restriction sites (see Figure 1).
            </P><FIGURE class="figure"><FIGCAPTION class="figure-caption"><STRONG>Figure 1:</STRONG> Primers overlapping the restriction sites are designed with a single nucleotide change to disrupt the restriction site. The primers anneal to the template plasmid and replicate while introducing the point mutation. The elongated plasmids are digested with the enzyme DpnI, which cleaves at the methylated sites breaking down the circular template, resulting in a higher transformation efficiency of the linear PCR product. </FIGCAPTION></FIGURE><DIV id="img1Modal" class="modal"><SPAN class="close img1">×</SPAN><DIV class="caption">DESCRIPTION</DIV></DIV><FIGURE class="figure"><FIGCAPTION class="figure-caption"><STRONG>Table 1:</STRONG> Primers designed for removal of illegal restriction sites. Bold marks the nucleotide  substitution.</FIGCAPTION></FIGURE><DIV id="img2Modal" class="modal"><SPAN class="close img2">×</SPAN><DIV class="caption">DESCRIPTION</DIV></DIV><P> 
            The new plasmid, <A href="http://parts.igem.org/Part:BBa_K2117012">BBa_K2117012</A>, with the removed AgeI restriction site was double digested with the enzyme and SpeI to test if we had successfully removed the AgeI restriction site. 
            </P><DIV class="row"><DIV class="col-md-6 col-sm-6"><FIGURE class="figure"><FIGCAPTION class="figure-caption"><STRONG>Figure 2:</STRONG> AgeI + SpeI digestion. Electrophoresis on a 1% agarose gel showing the digestion of  <A href="http://parts.igem.org/Part:BBa_K2117012">BBa_K2117012</A> (lane 1-3). <A href="http://parts.igem.org/Part:BBa_K530001">BBa_K530001</A>  digested with AgeI + SpeI and undigested <A href="http://parts.igem.org/Part:BBa_K530001">BBa_K530001</A> were used as controls (lane 4+5). </FIGCAPTION></FIGURE><DIV id="img3Modal" class="modal"><SPAN class="close img3">×</SPAN><DIV class="caption">DESCRIPTION</DIV></DIV></DIV><DIV class="col-md-6 col-sm-6"><P style="color:transparent;">    h</P></DIV></DIV><P>
            The digestion showed the removal of the AgeI restriction site, shown on the gel picture by only one band on the <A href="http://parts.igem.org/Part:BBa_K2117012">BBa_K2117012</A> compared to two bands on the control <A href="http://parts.igem.org/Part:BBa_K530001">BBa_K530001</A>. 
            </P><P><A href="http://parts.igem.org/Part:BBa_K2117012">BBa_K2117012</A> and <A href="http://parts.igem.org/Part:BBa_K2117013">BBa_K2117013</A>  were sent for sequencing with the verification primers VR and VF2 primers to further verify the removal of the restriction sites. 
            </P><DIV class="row"><DIV class="col-md-12"><FIGURE class="figure"><FIGCAPTION class="figure-caption"><STRONG>Figure 3:</STRONG> Sequencing alignment of BBa_530001 (top sequence) and  <A href="http://parts.igem.org/Part:BBa_K2117012">BBa_K2117012</A> (bottom sequence). The alignment shows a nucleotide substitution in the AgeI restriction site. </FIGCAPTION></FIGURE><DIV id="img4Modal" class="modal"><SPAN class="close img4">×</SPAN><DIV class="caption">DESCRIPTION</DIV></DIV></DIV><DIV class="col-md-12"><FIGURE class="figure"><FIGCAPTION class="figure-caption"><STRONG>Figure 4:</STRONG> Sequencing alignment of BBa_530002 (top sequence) and  <A href="http://parts.igem.org/Part:BBa_K2117013">BBa_K2117013</A> (bottom sequence). The alignment shows a nucleotide substitution in the BglII restriction site. </FIGCAPTION></FIGURE><DIV id="img5Modal" class="modal"><SPAN class="close img5">×</SPAN><DIV class="caption">DESCRIPTION</DIV></DIV></DIV></DIV><P>
                The sequencing results show a substitution in the restriction sites corresponding to the nucleotide substitution designed in the primers (Table 1). 
            </P><P>
                By deleting the two restriction sites in the <A href="http://parts.igem.org/Part:BBa_K2117012">BBa_K2117012</A> and <A href="http://parts.igem.org/Part:BBa_K2117013">BBa_K2117013</A> we have made the two BioBricks compatible with RFC25 and RFC21 standards, respectively.
            </P><H3 class="h3">Improvement of Characterization</H3><P>
                While working with <A href="http://parts.igem.org/Part:BBa_K530001">BBa_K530001</A>  and <A href="http://parts.igem.org/Part:BBa_K530002">BBa_K530002</A> we were struggling with assembly of the genes. Therefore, we sequenced the plasmids received in the distribution kit. 
            </P><P>
                Sequencing results of <A href="http://parts.igem.org/Part:BBa_K530002">BBa_K530002</A> showed nucleotide substitutions in the prefix and a large deletion in the suffix. 
            </P><FIGURE class="figure"><FIGCAPTION class="figure-caption"><STRONG>Figure 5:</STRONG> Alignment of <A href="http://parts.igem.org/Part:BBa_K530002">BBa_K530002</A> sequence received from the parts page (top) and sequencing results of <A href="http://parts.igem.org/Part:BBa_K530002">BBa_K530002</A> from the distribution kit. Alignment shows many nucleotide substitutions in the prefix seuqence. </FIGCAPTION></FIGURE><DIV id="img6Modal" class="modal"><SPAN class="close img6">×</SPAN><DIV class="caption">DESCRIPTION</DIV></DIV><FIGURE class="figure"><FIGCAPTION class="figure-caption"><STRONG>Figure 6:</STRONG> Alignment of <A href="http://parts.igem.org/Part:BBa_K530002">BBa_K530002</A> sequence received from the parts page (top) and sequencing results of <A href="http://parts.igem.org/Part:BBa_K530002">BBa_K530002</A> from the distribution kit. Alignment shows a deletion in the suffix sequence. </FIGCAPTION></FIGURE><DIV id="img7Modal" class="modal"><SPAN class="close img7">×</SPAN><DIV class="caption">DESCRIPTION</DIV></DIV><P> 
                The alterations in prefix and suffix make the <A href="http://parts.igem.org/Part:BBa_K530002">BBa_K530002</A> incompatible with the BioBrick standard
            </P></DIV></DIV><DIV class="col-md-3 col-sm-2 colRight" id="scrollspy"><UL class="nav" id="sidebar"><LI><A href="#section-1">Parts list</A></LI><LI><A href="#section-2">Improvement and Characterization</A></LI></UL></DIV></DIV></DIV></DIV><FOOTER id="footer"><DIV class="container"><DIV align="center" class="col-md-3"><UL><LI>FIND US AT:</LI></UL><UL><LI><U>DTU BIOBUILDERS</U></LI><LI>DENMARK</LI><LI>DTU - SØLTOFTS PLADS, BYGN. 221/002</LI><LI>2800 KGS. LYNGBY</LI><LI><U>E-mail:</U></LI><LI>dtu-biobuilders-2016@googlegroups.com</LI></UL></DIV><DIV align="center" class="col-md-6"><UL><LI>MAIN SPONSORS:</LI></UL></DIV></DIV></FOOTER></DIV></DIV></DIV></DIV></DIV></BODY></HTML>